Celestial Biolabs Limited reported earnings results for the fourth quarter and full year ended March 31, 2022. For the fourth quarter, the company reported sales was INR 0.631 million. Revenue was INR 0.631 million. Net loss was INR 2.75 million compared to INR 0.778 million a year ago. Basic loss per share from continuing operations was INR 0.12 compared to INR 0.03 a year ago. Diluted loss per share from continuing operations was INR 0.12 compared to INR 0.03 a year ago.
For the full year, sales was INR 1.48 million. Revenue was INR 1.48 million compared to INR 0.299 million a year ago. Net loss was INR 4.1 million compared to INR 1.71 million a year ago. Basic loss per share from continuing operations was INR 0.18 compared to INR 0.08 a year ago. Diluted loss per share from continuing operations was INR 0.18 compared to INR 0.08 a year ago.